Literature DB >> 22337133

Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation.

M Blomberg1, U Feldt-Rasmussen, K K Andersen, S K Kjaer.   

Abstract

Thyroid cancer incidence has increased worldwide during the previous decades. In this nationwide study, we aimed to identify the overall incidence of thyroid cancer in Denmark during 66 years (1943-2008) and incidences of the four main histological types of thyroid cancer from 1978 to 2008. Data were obtained from the nationwide Danish Cancer Registry, and we focused especially on the period after implementation of compulsory iodine supplementation, which was established on a national level in 2000. We calculated age-standardized incidence rates per 100,000 person-years, and age-period-cohort models were fitted to describe trends in incidence. To quantify trends in incidence over time, log-linear Poisson models were used to estimate annual percentage change. From 1943 to 2008, 1,947 men (29%) and 4,682 women (71%) were diagnosed with thyroid cancer. The age-standardized incidence increased in both sexes; in men from 0.41 to 1.57 per 100,000 and from 0.90 to 4.11 per 100,000 in women, corresponding to a significant average annual percentage change of 1.7 and 1.8%, respectively. The incidence increased with younger birth cohorts. The rise was almost exclusively caused by papillary carcinomas, and it was particularly present during the last decades of the study period. It cannot be ruled out that iodine supplementation may play a role for the risk of thyroid cancer, but as the strongest increase in incidence began in the years before the implementation, it is likely that improvement in diagnostic modalities increased diagnostic activity, and/or new unknown risk factors are also important contributors to the increase.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337133     DOI: 10.1002/ijc.27497

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  49 in total

1.  Urinary Iodine Concentration and Mortality Among U.S. Adults.

Authors:  Kosuke Inoue; Angela M Leung; Takehiro Sugiyama; Tetsuro Tsujimoto; Noriko Makita; Masaomi Nangaku; Beate R Ritz
Journal:  Thyroid       Date:  2018-07       Impact factor: 6.568

2.  Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records.

Authors:  Patrizio Caturegli; Alessandra De Remigis; Kelly Chuang; Marieme Dembele; Akiko Iwama; Shintaro Iwama
Journal:  Thyroid       Date:  2013-02       Impact factor: 6.568

Review 3.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 4.  Post-treatment surveillance of thyroid cancer.

Authors:  L Y Wang; I Ganly
Journal:  Eur J Surg Oncol       Date:  2017-07-19       Impact factor: 4.424

5.  Circular RNA circNEURL4 inhibits cell proliferation and invasion of papillary thyroid carcinoma by sponging miR-1278 and regulating LATS1 expression.

Authors:  Wei Ding; Ying Shi; Hong Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

6.  Benign Thyroid Diseases and Risk of Thyroid Cancer: A Nationwide Cohort Study.

Authors:  Cari M Kitahara; Dóra K Rmendiné Farkas; Jens Otto L Jørgensen; Deirdre Cronin-Fenton; Henrik Toft Sørensen
Journal:  J Clin Endocrinol Metab       Date:  2018-06-01       Impact factor: 5.958

7.  High prevalence of papillary thyroid microcarcinoma in danish patients: a prospective study of 854 consecutive patients with a cold thyroid nodule undergoing fine-needle aspiration.

Authors:  Maria Rossing; Birte Nygaard; Finn Cilius Nielsen; Finn Noe Bennedbæk
Journal:  Eur Thyroid J       Date:  2012-06-08

8.  Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.

Authors:  Sunmi Park; Mark C Willingham; Jun Qi; Sheue-Yann Cheng
Journal:  Endocr Relat Cancer       Date:  2018-06-18       Impact factor: 5.678

9.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

10.  Cost-effectiveness analysis of papillary thyroid cancer surveillance.

Authors:  Laura Y Wang; Benjamin R Roman; Jocelyn C Migliacci; Frank L Palmer; R Michael Tuttle; Ashok R Shaha; Jatin P Shah; Snehal G Patel; Ian Ganly
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.